Section Arrow
PLSE.NASDAQ
- Pulse Biosciences
Quotes are at least 15-min delayed:2025/11/14 23:11 EST
Regular Hours
Last
 14.4
+0.26 (+1.84%)
Day High 
14.7545 
Prev. Close
14.14 
1-M High
18.435 
Volume 
214.32K 
Bid
14.4
Ask
15.92
Day Low
13.9 
Open
14 
1-M Low
14 
Market Cap 
958.23M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 15.71 
20-SMA 16.62 
50-SMA 17.04 
52-W High 25 
52-W Low 13.7658 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.14/-1.66
Enterprise Value
965.78M
Balance Sheet
Book Value Per Share
1.37
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
MLSSMilestone Scientific0.33-0.0497-13.09%-- 
AVTRAvantor11.38-0.32-2.74%11.55PE
BAXBaxter International18.47-0.23-1.23%140.32PE
HOLXHologic74.15-0.11-0.15%30.81PE
XRAYDENTSPLY SIRONA10.52-0.43-3.93%-- 
Quotes are at least 15-min delayed:2025/11/14 23:11 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.